Eleonora Lad, MD, PhD was featured in a patient education video about the new treatment available for geographic atrophy (GA).
The drug, pegcetacoplan, is the first ever FDA-approved treatment for GA, which affects about one million people in the United States and five million worldwide. Lad was a lead investigator in the OAKS trial, a pivotal clinical trial that supported the FDA approval of this treatment.